Bakker, Guido J <br/><br/>
Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.  [electronic resource] 

 -  Physiological reports  08 2019 
 - e14199 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-817X 
<br/><br/><label>Standard No.: </label>10.14814/phy2.14199  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Bacterial Agents--pharmacology<br/>Dietary Fats--adverse effects<br/>Gastrointestinal Microbiome--drug effects<br/>Humans<br/>Inflammation--metabolism<br/>Lipopolysaccharides--blood<br/>Male<br/>Metabolic Syndrome--metabolism<br/>Middle Aged<br/>Monocytes--drug effects<br/>Obesity--metabolism<br/>Postprandial Period--drug effects<br/>Vancomycin--pharmacology